Literature DB >> 9548449

Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells.

Y Ohnishi1, H Fujii, Y Hayakawa, R Sakukawa, T Yamaura, T Sakamoto, K Tsukada, M Fujimaki, S Nunome, Y Komatsu, I Saiki.   

Abstract

We have investigated the inhibitory effect of oral administration of Juzen-taiho-to, a Kampo Japanese herbal medicine, on liver metastasis by the inoculation of a liver-metastatic variant (L5) of murine colon 26 carcinoma cells into the portal vein. Oral administration of Juzen-taiho-to for 7 days before tumor inoculation resulted in dose-dependent inhibition of liver tumor colonies and significant enhancement of survival rate as compared with the untreated control, without side effects. We also found that liver metastasis of L5 cells was enhanced in BALB/c mice pretreated with anti-asialo GM1 serum or 2-chloroadenosine, and in BALB/c nu/nu mice, compared to normal mice. This indicates that NK cells, macrophages, and T-cells play important roles in the prevention of metastasis of tumor cells. Juzen-taiho-to significantly inhibited the experimental liver metastasis of colon 26-L5 cells in mice pretreated with anti-asialo GM1 serum and untreated normal mice, whereas it did not inhibit metastasis in 2-chloroadenosine-pretreated mice or T-cell-deficient nude mice. Oral administration of Juzen-taiho-to activated peritoneal exudate macrophages (PEM) to become cytostatic against the tumor cells. These results show that oral administration of Juzen-taiho-to inhibited liver metastasis of colon 26-L5 cells, possibly through a mechanism mediated by the activation of macrophages and/or T-cells in the host immune system. Thus, Juzen-taiho-to may be efficacious for the prevention of cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548449      PMCID: PMC5921762          DOI: 10.1111/j.1349-7006.1998.tb00550.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  23 in total

1.  Patterns of recurrence after curative resection of carcinoma of the colon and rectum.

Authors:  S Galandiuk; H S Wieand; C G Moertel; S S Cha; R J Fitzgibbons; J H Pemberton; B G Wolff
Journal:  Surg Gynecol Obstet       Date:  1992-01

2.  The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy.

Authors:  S Bengmark; L Hafström
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

3.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

4.  Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs.

Authors:  K Haranaka; N Satomi; A Sakurai; R Haranaka; N Okada; M Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.

Authors:  T J Gayowski; S Iwatsuki; J R Madariaga; R Selby; S Todo; W Irish; T E Starzl
Journal:  Surgery       Date:  1994-10       Impact factor: 3.982

6.  Characterization of mitogenic pectic polysaccharides from kampo (Japanese herbal) medicine "juzen-taiho-to".

Authors:  H Kiyohara; N Takemoto; Y Komatsu; H Kawamura; E Hosoya; H Yamada
Journal:  Planta Med       Date:  1991-06       Impact factor: 3.352

7.  Improvement of cisplatin toxicity and lethality by juzen-taiho-to in mice.

Authors:  K Sugiyama; H Ueda; Y Ichio; M Yokota
Journal:  Biol Pharm Bull       Date:  1995-01       Impact factor: 2.233

8.  Protective effect of juzen-taiho-to against carboplatin-induced toxic side effects in mice.

Authors:  K Sugiyama; H Ueda; Y Ichio
Journal:  Biol Pharm Bull       Date:  1995-04       Impact factor: 2.233

9.  2-Chloroadenosine: a selective lethal effect to mouse macrophages and its mechanism.

Authors:  T Saito; J Yamaguchi
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  Inhibitory effect of a traditional Chinese medicine, Juzen-taiho-to, on progressive growth of weakly malignant clone cells derived from murine fibrosarcoma.

Authors:  Y Ohnishi; H Fujii; F Kimura; T Mishima; J Murata; K Tazawa; M Fujimaki; F Okada; M Hosokawa; I Saiki
Journal:  Jpn J Cancer Res       Date:  1996-10
View more
  17 in total

1.  Antitumor and immunomodulatory effects of weikangfu granule compound in tumor-bearing mice.

Authors:  Xiaohua Nie; Baojun Shi; Yuting Ding; Wenyi Tao
Journal:  Curr Ther Res Clin Exp       Date:  2006-03

2.  Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.

Authors:  Lin Ye; Yongning Jia; K E Ji; Andrew J Sanders; Kan Xue; Jiafu Ji; Malcolm D Mason; Wen G Jiang
Journal:  Oncol Lett       Date:  2015-07-06       Impact factor: 2.967

3.  Biomarker-guided screening of Juzen-taiho-to, an oriental herbal formulation for immunostimulation.

Authors:  Anna Takaoka; Maria Iacovidou; Tal H Hasson; Diego Montenegro; Xiangming Li; Moriya Tsuji; Akira Kawamura
Journal:  Planta Med       Date:  2014-02-18       Impact factor: 3.352

Review 4.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

5.  Immunostimulatory lipid nanoparticles from herbal medicine.

Authors:  Tal H Hasson; Anna Takaoka; Roberto de la Rica; Hiroshi Matsui; Gabriela Smeureanu; Charles M Drain; Akira Kawamura
Journal:  Chem Biol Drug Des       Date:  2014-02-05       Impact factor: 2.817

Review 6.  Chinese medical herbs for chemotherapy side effects in colorectal cancer patients.

Authors:  W Taixiang; A J Munro; L Guanjian
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

7.  Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine.

Authors:  Shigeru Yutani; Nobukazu Komatsu; Satoko Matsueda; Munehiro Yoshitomi; Takahisa Shirahama; Akira Yamada; Kyogo Itoh; Tetsuro Sasada
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-10       Impact factor: 2.629

8.  Suppressive effect of juzen-taiho-to on lung metastasis of b16 melanoma cells in vivo.

Authors:  Takako Matsuda; Katsuhiko Maekawa; Kazuhito Asano; Tadashi Hisamitsu
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-05       Impact factor: 2.629

9.  IL-12 and IL-18 induction and subsequent NKT activation effects of the Japanese botanical medicine Juzentaihoto.

Authors:  Kazuhiko Fujiki; Masanori Nakamura; Takako Matsuda; Mariko Isogai; Minako Ikeda; Yutaka Yamamoto; Mari Kitamura; Naoko Sazaki; Fumiatsu Yakushiji; Shinji Suzuki; Junji Tomiyama; Takashi Uchida; Ken Taniguchi
Journal:  Int J Mol Sci       Date:  2008-07-08       Impact factor: 6.208

Review 10.  The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo.

Authors:  Marie Amitani; Haruka Amitani; Robert A Sloan; Hajime Suzuki; Nanami Sameshima; Akihiro Asakawa; Yasuhito Nerome; Tetsuhiro Owaki; Akio Inui; Etsuo Hoshino
Journal:  Front Pharmacol       Date:  2015-08-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.